John K. Hall

1.9k total citations · 1 hit paper
14 papers, 1.3k citations indexed

About

John K. Hall is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, John K. Hall has authored 14 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Genetics and 4 papers in Surgery. Recurrent topics in John K. Hall's work include Muscle Physiology and Disorders (13 papers), Virus-based gene therapy research (4 papers) and Tissue Engineering and Regenerative Medicine (4 papers). John K. Hall is often cited by papers focused on Muscle Physiology and Disorders (13 papers), Virus-based gene therapy research (4 papers) and Tissue Engineering and Regenerative Medicine (4 papers). John K. Hall collaborates with scholars based in United States, Poland and United Kingdom. John K. Hall's co-authors include Bradley B. Olwin, Kathleen Kelly, Jeffrey S. Chamberlain, Jason D. Doles, Guy L. Odom, Joel R. Chamberlain, Niclas E. Bengtsson, Glen B. Banks, Stephen D. Hauschka and Colin Andrus and has published in prestigious journals such as Nucleic Acids Research, Nature Medicine and Nature Communications.

In The Last Decade

John K. Hall

14 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

p38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice

2014 425 citations Jason D. Doles, John K. Hall et al. Nature Medicine profile →

Peers

Countries citing papers authored by John K. Hall

Since Specialization

Citations

This map shows the geographic impact of John K. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John K. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John K. Hall more than expected).

Fields of papers citing papers by John K. Hall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John K. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John K. Hall. The network helps show where John K. Hall may publish in the future.

Co-authorship network of co-authors of John K. Hall

This figure shows the co-authorship network connecting the top 25 collaborators of John K. Hall. A scholar is included among the top collaborators of John K. Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John K. Hall. John K. Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	HCR spectral imaging: 10-plex, quantitative, high-resolution RNA and protein imaging in highly autofluorescent samples 2024 ·Development ·(unknown), Mark E. Fornace, John K. Hall, (unknown), Niles A. Pierce	7
2	Efficacy and muscle safety assessment of fukutin-related protein gene therapy 2023 ·Molecular Therapy — Methods & Clinical Development ·(unknown), (unknown), Jane T. Seto, John K. Hall, Christine L. Halbert, Jacqueline Wicki, (unknown), (unknown), Michael Regnier, David C. Lin, Buel D. Rodgers, Jeffrey S. Chamberlain	5
3	Enhanced exon skipping and prolonged dystrophin restoration achieved by TfR1-targeted delivery of antisense oligonucleotide using FORCE conjugation in mdx mice 2022 ·Nucleic Acids Research ·Cody A. Desjardins, (unknown), John K. Hall, Emma O’Donnell, (unknown), Sean Spring, Aiyun Wen, Nelson Hsia, Peiyi Shen, (unknown), Bo Lan, Tyler Picariello, Kim San Tang, Timothy Weeden, Stefano Zanotti, Romesh R. Subramanian, Oxana Ibraghimov‐Beskrovnaya	42
4	Gene Therapy Rescues Cardiac Dysfunction in Duchenne Muscular Dystrophy Mice by Elevating Cardiomyocyte Deoxy-Adenosine Triphosphate 2019 ·JACC Basic to Translational Science ·Stephen C. Kolwicz, John K. Hall, Farid Moussavi‐Harami, (unknown), Stephen D. Hauschka, Jeffrey S. Chamberlain, Michael Regnier, Guy L. Odom	18
5	Transplantation of Skeletal Muscle Stem Cells 2017 ·Methods in molecular biology ·(unknown), John K. Hall, Adam B. Cadwallader, Bradley Pawlikowski, Jason D. Doles, (unknown), Bradley B. Olwin	11
6	Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy 2017 ·Nature Communications ·Niclas E. Bengtsson, John K. Hall, Guy L. Odom, Michael Phelps, Colin Andrus, R. David Hawkins, Stephen D. Hauschka, Joel R. Chamberlain, Jeffrey S. Chamberlain	305
7	Progress and prospects of gene therapy clinical trials for the muscular dystrophies 2015 ·Human Molecular Genetics ·Niclas E. Bengtsson, Jane T. Seto, John K. Hall, Jeffrey S. Chamberlain, Guy L. Odom	50
8	Myofiber branching rather than myofiber hyperplasia contributes to muscle hypertrophy in mdx mice 2014 ·Skeletal Muscle ·(unknown), John K. Hall, Jeffrey S. Chamberlain, Glen B. Banks	40
9	Adeno-associated viral vectors do not efficiently target muscle satellite cells 2014 ·Molecular Therapy — Methods & Clinical Development ·Andrea Arnett, Patryk Konieczny, Julian N. Ramos, John K. Hall, Guy L. Odom, Zipora Yablonka‐Reuveni, Joel R. Chamberlain, Jeffrey S. Chamberlain	81
10	p38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice breakdown → 2014 ·Nature Medicine ·(unknown), Jason D. Doles, John K. Hall, Kathleen Kelly, (unknown), Bradley B. Olwin	425
11	Activation of Notch Signaling During Ex Vivo Expansion Maintains Donor Muscle Cell Engraftment 2012 ·Stem Cells ·Maura H. Parker, Carol Loretz, Ashlee E. Tyler, William Duddy, John K. Hall, Bradley B. Olwin, Irwin D. Bernstein, Rainer Storb, Stephen J. Tapscott	44
12	Animal Models of Muscular Dystrophy 2011 ·Progress in molecular biology and translational science ·Rainer Ng, Glen B. Banks, John K. Hall, Lindsey A. Muir, Julian N. Ramos, Jacqueline Wicki, Guy L. Odom, Patryk Konieczny, Jane T. Seto, Joel R. Chamberlain, Jeffrey S. Chamberlain	36
13	Prevention of Muscle Aging by Myofiber-Associated Satellite Cell Transplantation 2010 ·Science Translational Medicine ·John K. Hall, Glen B. Banks, Jeffrey S. Chamberlain, Bradley B. Olwin	94
14	Syndecan-4-Expressing Muscle Progenitor Cells in the SP Engraft as Satellite Cells during Muscle Regeneration 2009 ·Cell stem cell ·Kathleen Kelly, John K. Hall, (unknown), DDW Cornelison, Susan M. Majka, Bradley B. Olwin	180

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact